ABSTRACT Hybridization probes derived from the A and B subunit genes ofthe heat-labile enterotoxin (LT) ofEscherichia coli were used to analyze DNA from Vibrio cholerae strain 569B for cholera toxin gene sequences. Southern blot analysis indicated that the cholera toxin A and B subunit genes were each duplicated in this strain. One of the two toxin subunit gene pairs was cloned as a 5. 1-kilobase DNA insert in plasmid pBR322. E. coli cells carrying the recombinant plasmid pJM17 were shown to produce cholera toxin, which was found to be largely cell associated. Protein chemical analysis indicated that the toxin was in its unnicked form and required additional proteolytic processing by trypsin to exhibit full toxicity in tissue culture. The alteration in E. coli ofthe secretion and proteolytic processing of cholera toxin parallels that previously observed for LT. An in vitro generated insertion mutation in the A subunit gene on pJM17 was shown to abolish production of the A chain but still allow production of the B chain. These observations, together with restriction mapping data, have demonstrated that the cholera toxin and LT genes are very similar in their genetic organization.
Cholera toxin and the heat-labile enterotoxin (LT) of Escherichia coli share many structural and genetic properties. Both toxins are multimeric proteins composed of two types of subunits, A and B (1) (2) (3) (4) . The A subunits (Mr 25,000-28,000) are the enzymically active moieties of the toxins and are known to promote the activation of adenylate cyclase in eukaryotic cells by catalyzing the ADP-ribosylation of a GTPase regulatory component ofthe cyclase complex (5, 6) . The B subunits (Mr 11, 600) are present in five copies per toxin molecule and display a high binding affinity for the toxins' probable cell surface receptor, ganglioside GM1 (2, 7). The two toxins have been found to possess both common and unique antigenic determinants (8) . The DNA sequences of the cloned genes coding for the LT A and B subunits have been largely determined and have been predicted to code for polypeptides that show a high degree of homology with the known amino acid sequences of the cholera toxin subunits (9, 10) . Furthermore, Southern blot hybridization, utilizing probes derived from the two LT structural genes, has demonstrated that toxinogenic strains of Vibrio cholerae possess DNA sequences homologous to the LT genes (11, 12) . The conclusion that this homologous DNA contains the structural genes for cholera toxin is supported by the observation that certain nontoxinogenic mutants of V. cholerae have lost all or part of these DNA sequences (13) .
Although the above discussion outlines some of the striking similarities in the protein and nucleic acid chemistry of LT and cholera toxin, several differences can be noted. The level of toxin production by V. cholerae varies widely between strains but is generally much higher than LT production by enterotoxinogenic strains of E. coli (14) . Cholera toxin is found primarily as an extracellular protein and is presumably secreted by V. cholerae. In contrast, the LT produced by E. coli remains tightly cell associated and may exist as an outer membrane or periplasmic protein (4, 15) . A possibly related observation involves the relative extent ofproteolytic processing sustained by each of these toxins. Whereas the A subunit of cholera toxin is generally found in a "nicked" form consisting ofdisulfide-linked A1 (Mr 22,000) and A2 (Mr 6,000) peptides, the A subunit of LT is usually composed of a single, unnicked A chain (Mr 25,500-28,000) (3, 4, 16) .
Do the reasons for these differences lie mainly at the level of the specific toxin genes or might they be more related to the particular host organism in which the toxin genes reside? One possible means of answering this question as well as investigating other aspects oftoxinogenesis is through the introduction ofthe cholera toxin gene into E. coli via recombinant DNA technology. Moreover, the in vitro alteration of the cloned toxin gene would offer a powerful approach to the construction of toxin mutations that might have practical value in cholera vaccine development.
In this report we describe the cloning in E. coli of a V. cholerae DNA fragment that codes for production of cholera toxin. We have found that both the secretion and the proteolytic processing of the toxin subunits are altered in the E. coli clone in a manner similar to that previously reported for LT. The genetic organization of the cholera toxin A and B subunit genes is also analogous to that of the LT cistrons.
MATERIALS AND METHODS Bacterial Strains. V. cholerae 569B (prototrophic, Inaba serotype) and E. coli MS371 (same as SK1592, from Sidney Kushner; F-gal thi endA sbcB hsdR4 hsdM+) were maintained at -70'C in CYE broth (17) containing 15% (vol/vol) glycerol or on LB plates (18) . Plasmid content of a strain is given in parentheses after its name.
Toxin Production and Assays. Bacteria were grown in CYE broth at 300C for 18 hr with vigorous aeration. The cells were collected by centrifugation and cell extracts were prepared as follows. Cells were resuspended in an equal volume of 25 mM Tris-HCl buffer, pH 8.0/10 mM EDTA/8 ,Ag ofphenylmethylsulfonyl fluoride per ml/3 mg of lysozyme per ml. After incubating 15 min at 220C the solution was frozen at -700C and thawed at 37°C. This was repeated four times and then DNase I and MgCl2 were added to 10 ,g/ml and 10 mM, respectively. Centrifugation at 20,000 X g for 15 min produced a clear supernatant extract, which was stored at -70°C until used in toxin assays.
Abbreviations: LT, heat-labile enterotoxin of E. coli; LT-A and LT-B, the A and B subunits of LT; kb, kilobase(s); ELISA, enzyme-linked immunosorbent assay.
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Toxin antigen was measured with an enzyme-linked immunosorbent assay (ELISA) performed essentially as described by Holmgren (19) . Toxic activity was measured in the S49 mouse lymphosarcoma cell assay (20) . Purified cholera toxin (17) was used as the standard in the above assays.
DNA Preparation and Analysis. DNA was prepared from bacterial cells by the method of Brenner et aL (21) . DNA restriction enzymes and phage T4 DNA ligase were purchased from New England BioLabs and T4 DNA polymerase from Bethesda Research Laboratories. These enzymes were used under conditions suggested by the suppliers. LT sequence probes were prepared from plasmid EWD299 (22) by the methods of Moseley and Falkow (11) . The LT-A probe was a 770-base pair Xba I/EcoRI fragment and the LT-B probe was a 590-base pair EcoRI/HindIII fragment ofEWD299 (Fig. 2) . These fragments and DNA molecular weight standards were labeled with [a-32P]dCTP (New England Nuclear) by the method of Maniatis et aL (23) to a specific activity of about 108 cpm/gg. Electrophoresis in 0.7% agarose gels and Southern blot hybridization on nitrocellulose sheets (Schleicher & Schuell) were performed as described (24) .
Protein Analysis in Recombinant Strains. Strains were radioactively labeled by growing cells for 18 hr in 5 ml of M63 glucose minimal broth (18) containing 2 mM each of 19 nonradioactive amino acids (no methionine), and 100 pCi (1 Ci = 3.7 x 1010 becquerels) of [fS]methionine (New England Nuclear). Cells were harvested and lysed as described above for toxin assays. Immunoadsorption with rabbit antitoxin and formalin-treated Staphylococcus aureus was performed essentially as described (25) . The adsorbed proteins were solubilized from the immune complexes by boiling in NaDodSO4 sample buffer and were then electrophoresed in 15% polyacrylamide/ NaDodSO4 gels as described (26) . The gels were treated with EN3HANCE (New England Nuclear), dried, and autoradiographed at -70°C, using X-AR5 film (Eastman). RESULTS Southern Blot Analysis of V. cholerae 569B. V. cholerae 569B is a strain that has been widely used in studies addressing the protein chemistry and genetics ofcholera toxin. On the basis ofresults of Southern blot hybridization utilizing LT-A and LT-B gene probes, Moseley and Falkow (11) Digestion of 569B DNA with both enzymes simultaneously also resulted in the generation of two bands, one of which comigrated with the 5.4-kb Pst I band and was presumably identical. The 5. 1-kb band in the double digest was smaller than either one of the two Pst I or EcoRI bands and was therefore likely to be a Pst I/EcoRI subfragment derived from the 9.5-kb Pst I fragment.
An identical Southern blot was also hybridized with the LT-B probe and the same bands were found to hybridize (Fig. 1) . Because Cloning ofthe Cholera Toxin A and B Subunit Genes. Strain 569B DNA, doubly digested with EcoRI and Pst I, was fractionated by electrophoresis in a 0. 7% agarose gel. The DNA in the area of the gel containing fragments in about the 4.5-to 5.5-kb range was recovered from the gel by electroelution followed by ethanol precipitation. This DNA fraction (20 ng) was mixed with pBR322 (27) DNA (100 ng) that had been previously digested with both EcoRI and Pst I and treated with alkaline phosphatase. The mixture was treated with T4 ligase, introduced into E. coli MS371 by transformation, and plated on LB plates containing tetracycline at 15 ,g/ml. Tetracycline-resistant colonies that were ampicillin sensitive were identified and then tested for the presence of the cholera toxin A subunit gene by using the LT-A probe and the colony hybridization method of Gruenstein and Hogness (28) .
A colony displaying a positive hybridization signal was identified by this method and the plasmid it contained was purified. Southern blot analysis confirmed that this plasmid, pGP1, contained a 5.1-kb Pst I/EcoRI fragment that hybridized to the LT-A probe (data not shown). However, additional restriction analysis indicated that pGP1 also contained two additional small Pst I/EcoRB inserts ofabout 500 base pairs each (Fig. 2 ). These were deleted from pGP1 by digestion of the plasmid with EcoRI followed by ligation to give plasmid pJM17, which contained only a single 5.1-kb Pst I/EcoRI insert in pBR322. This insert was shown to contain both toxin A and B gene sequences in Southern blots and was found to comigrate with the 5.1-kb Pst I/EcoRI fragment detectable in 569B digests (Fig. 1) . Digestion of pJM17 with Pst I alone produced the linearized plasmid, which was 8.7 kb in length.
Expression and Molecular Properties of Cholera Toxin Encoded by pJM17. Cell-free culture fluid and cell extracts of MS371(pJM17), MS371(pBR322), and V. cholerae 569B were assayed for cholera toxin activity and antigen by the S49 tissue culture assay and the ELISA assay. Table, 1 shows that MS371(pJM17) produced cholera toxin detectable in both assays, whereas the control culture MS371(pBR322) was negative in these assays. However, in contrast to 569B, which released greater than 99% of its toxin antigen into the culture fluid, the toxin produced by MS371(pJM17) remained about 94% cell-associated. Other studies indicated that the cell-bound toxin was not substantially released by treatment of MS371(pJM17) cells with an osmotic shock (data not shown). These data suggest that secretion of cholera toxin by 569B is probably a consequence of the physiology of V. cholerae and not an inherent property of the cholera toxin gene.
The cholera toxin produced by MS371(pJM17) was lower in specific toxicity than the toxin produced by 569B (Table 1) . However, treatment of the MS371(pJM17) cell extract with trypsin resulted in a 260-fold increase in specific toxicity to a level equal to that of purified toxin (Table 1) . Cholera antitoxin neutralized the toxic activity present in the MS371(pJM17) extract both before and after digestion with trypsin. Trypsin at the level used in the experiments was devoid of S49 toxicity. These results suggested that the toxin produced by MS371(pJM17) was in a precursor form that required additional proteolytic processing to express full toxicity.
We examined the molecular nature of the toxin polypeptide chains produced by MS371(pJM17) in M63 medium containing [3S]methionine. Cell-free culture fluid and cell extracts were prepared as before for MS371(pJM17) and a portion of the MS371(pJM17) cell extract was also digested with trypsin under conditions known to enhance the toxicity of this extract. The toxin-related polypeptides were prepared from the extracts by immunoadsorption using antitoxin and formalin-treated S. aureus. Figure 3 shows that analysis ofthese preparations by electrophoresis in NaDodSOjpolyacrylamide gels and autoradiography revealed that MS371(pJMl7) produced two polypeptide chains that were specifically immunoadsorbed from the cell extracts. One polypeptide (Mr 28,000) comigrated with the unnicked A chain of cholera toxin and the other comigrated with the B subunit of the toxin. Two peptides were also immunoadsorbed from the trypsin-treated MS371(pJM17) extract. One of these again comigrated with the cholera toxin B subunit; however, the other (Mr 22,000) comigrated with the Al peptide of cholera toxin. Peptides comigrating with the A2 polypeptide of cholera toxin are not resolved well from the B subunit in this gel system. These data indicate that MS371(pJM17) produces cholera toxin that is primarily in its unnicked form (16 (20) Proc. Nad Acad. Sci. USA 79 (1982) form of the toxin to the nicked form composed ofthe disulfidelinked Al and A2 peptides (16) . These data also suggest that the increase in specific toxicity seen after trypsin digestion of MS371(pJM17) extracts (Table 1) is also due to the cleavage of the unnicked A chain by trypsin. Localization of the Cholera Toxin Genes on pJM17 by Hybridization and in Vitro Mutagenesis. Restriction analysis of pJM17 was performed with EcoRI, Pst I, Xba I, HincII, and Pvu I, and the DNA fragments in these digests containing sequences homologous to the LT-A probe were identified by Southern hybridization (Fig. 4) . A similar hybridization analysis was performed with the LT-B probe (data not shown). A 1.8-kb Xba I/ Pvu [-fragment of pJM17 was the smallest fragment containing all sequences homologous to both the LT-A and LT-B probes. Sequences homologous to the LT-A probe were found to reside only on a 950-base pair Xba I/HincII fragment, whereas sequences homologous to the LT-B probe were present on both the latter fragment and a -1,050-base pair HincII/Pvu I fragment. These data, together with other restriction data presented in Fig. 4 , allowed us to deduce the restriction map of pJM17 and the location of the toxin subunit genes on this plasmid (Fig. 2) . The relative order of the cholera toxin A and B subunit genes on pJM17 suggests that the Xba I site on this plasmid may be analogous in location to the Xba I site used to make the LT-A probe. This Xba I site corresponds to amino acids 10 and 11 of the LT-A chain and is located in a region (amino acids [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] known to display 100% amino acid sequence homology with the cholera A subunit (10).
We.have obtained additional evidence that the Xba I site on pJM17 is located within the A subunit gene by analyzing the effect on toxin production of an insertion mutation constructed in vitro at this restriction enzyme site. Plasmid pJM17 was digested with Xba I to completion and the single-stranded 5 size. MS371(pJM18) produced about one-fifth as much toxin antigen as MS371(pJM17) did. However, the toxin antigen produced by MS371(pJMl8) was devoid-of toxicity in the S49 assay both before and after trypsin treatment ( Table 1) . Analysis of the antigen produced by MS371(pJM18) by immunoadsorption and NaDodSO4polyacrylamide gel electrophoresis demonstrated that this antigen consisted only-ofthe B subunit ofcholera toxin (Fig. 3) .
We conclude that the Xba I site on pJM17 is localized within the A subunit gene because introduction ofan insertional frameshift mutation at this site eliminated production of-the A chain. Furthermore, it is known that nonsense and frameshift mutations in a proximal gene of an operon will frequently result in reduced expression of distal genes due to p-mediated transcriptional termination (29, 30) . ' The reduction of B subunit production to one-fifth observed with MS371(pJM18) therefore suggests that the order of transcription of the toxin subunit genes is A followed by B. This in turn predicts that a promoter for the toxin genes probably resides within the 2.7-kb Pst I/Xba I fragment of pJM17 as indicated in Fig. 2 .
DISCUSSION
Previous protein chemical analysis ofpurified cholera toxin and LT had established their remarkable biochemical similarity (3, 4) . Our analysis of the cloned cholera toxin gene has indicated that the cholera toxin and LT genes are also highly similar in their genetic organization (Fig. 2) . Direct comparison of the nucleotide sequences of the cholera toxin and LT genes is now possible and may yield valuable insights into the evolution of these two related toxins and possibly other ADP-ribosylating toxins such as diphtheria toxin and exotoxin A of Pseudomnas aeruginosa (1) .
Expression of the cholera toxin genes in E. coli has. allowed us to make several observations concerning the secretion and proteolytic processing of'the toxin's polypeptides. The lack of significant release of cholera toxin by the E. coli cells suggests that V. cholerae possesses a protein secretory apparatus that either is lacking in E. coli or is defective in its recognition ofthe cholera toxin-polypeptide secretory signals. Although E. coli has shown the capacity to secrete a variety ofproteins into its periplasm and outer membrane, examples oftrue extracellular protein secretion by this species are rare (31) (32) (33) . The fact that LT, the indigenous E.-coli enterotoxin, is also primarily cell associated further supports the existence ofan extracellular protein secretory defect in E. coli relative to other pathogenic Gramnegative organisms (e.g., members of Vibrio, Shigella, Pseudomonas, and BordetellUa).
The observed defect in the proteolytic processing of the A subunits of both cholera toxin and LT (4) might also be related to the failure ofE. coli to secrete these toxins. Because the unnicked forms of these toxins are deficient in both enzymic (16) and toxic activity (4), the defect in the secretion and processing ofthese enterotoxins might indeed explain the reduced severity of E. coli-induced enterotoxic disease when compared to cholera (4) .
It is of interest to note that the total amount of cholera toxin produced by MS371(pJM18) was only 4% the amount made by V. cholerae 569B. Strain 569B possesses two copies ofthe toxin operon, and the relative expression of these two copies is not known. However, because the copy number of pJM17 is approximately 10 plasmid molecules per cell, the amount of toxin produced by MS371(pJM17) is still quite low by comparison. Perhaps the secretory block in E. coli has also resulted in a net decrease in toxin accumulation due to the degradative turnover of cell-bound or intracellular toxin. Alternatively, E. coli might not recognize V. cholerae promoters efficiently or might lack some positive control element produced by V. cholerae that promotes the high expression of the toxin genes (34) . The molecular cloning of the cholera toxin gene has allowed us to employ recombinant DNA technology in the construction of an in vitro generated mutation in the A subunit gene. This has demonstrated the feasibility of constructing plasmids that code for production of only the B subunit of the toxin. Because this subunit is both nontoxic and highly immunogenic, plasmids such as pJM18 might be highly useful in the production ofcholera toxoids. Alternatively, the introduction ofthis or other analogous in vitro altered toxin genes back into wild-type or mutant strains (13) of V. cholerae could facilitate construction of a V. cholerae strain suitable for testing as a live oral cholera vaccine.
